<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04968392</url>
  </required_header>
  <id_info>
    <org_study_id>17300626</org_study_id>
    <nct_id>NCT04968392</nct_id>
  </id_info>
  <brief_title>Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty</brief_title>
  <official_title>Analgesic Efﬁcacy of Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total knee arthroplasty surgery is associated with severe postoperative pain and adequate&#xD;
      pain management is necessary for early postoperative mobilization and rehabilitation.&#xD;
      Although good postoperative pain control may be achieved by continuous epidural anesthesia or&#xD;
      femoral nerve block, both methods have adverse effects such as muscle weakness, which may&#xD;
      delay postoperative mobilization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The adductor canal block (ACB) is a relatively new block providing analgesia for knee&#xD;
      surgery, which not only blocks the largest sensory branch of the femoral nerve but also&#xD;
      results in less reduction of quadriceps muscle strength, compared with the femoral nerve&#xD;
      block (FNB) in adult patients.&#xD;
&#xD;
      Randomized controlled trials have revealed that ACB provides at least equal analgesia as FNB,&#xD;
      preserves quadriceps muscle strength better than FNB, and thus allowing for functional&#xD;
      recovery within the first 24-hour post-TKA. However, one important limitation of single-shot&#xD;
      peripheral nerve block is the short duration of analgesia. Because the average duration of&#xD;
      severe pain after TKA takes 2-3 days, a continuous ACB via catheter would seem to be a good&#xD;
      choice. Unfortunately, perineural catheters may be technically difficult to insert, are prone&#xD;
      to premature dislodgement, and may increase infection risk. There also were some case reports&#xD;
      of local anesthetic-induced myotoxicity after continuous ACB.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">May 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the first analgesia rescue call.</measure>
    <time_frame>24 hours postoperative</time_frame>
    <description>time to the first analgesic request.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Adductor Canal Block</condition>
  <condition>Levobupivacaine</condition>
  <condition>Dexmedetomidine</condition>
  <arm_group>
    <arm_group_label>L group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 mL of 0.25% levobupivacaine plus 1 mL normal saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LD group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 mL of 0.25% levobupivacaine plus 0.5 µg/kg dexmedetomidine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine Hydrochloride</intervention_name>
    <description>20 mL of 0.25% levobupivacaine plus 0.5 µg/kg dexmedetomidine</description>
    <arm_group_label>LD group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>20 mL of 0.25% levobupivacaine plus 1 mL normal saline</description>
    <arm_group_label>L group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA physical status I or II&#xD;
&#xD;
          -  undergoing elective primary total knee arthroplasty surgery under spinal anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with a known history of significant hepatic,&#xD;
&#xD;
          -  renal, heart disease, autoimmune disease,&#xD;
&#xD;
          -  any known convulsive disorder, any psychiatric disorders, chronic pain,&#xD;
&#xD;
          -  pregnant females, regular use analgesics, anti-depressants, or opioids in the previous&#xD;
             2 months, revision surgery, morbid obesity, allergy to local anesthetics or morphine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assiut governorate</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Bauer MC, Pogatzki-Zahn EM, Zahn PK. Regional analgesia techniques for total knee replacement. Curr Opin Anaesthesiol. 2014 Oct;27(5):501-6. doi: 10.1097/ACO.0000000000000115. Review.</citation>
    <PMID>25111605</PMID>
  </reference>
  <reference>
    <citation>Jæger P, Koscielniak-Nielsen ZJ, Schrøder HM, Mathiesen O, Henningsen MH, Lund J, Jenstrup MT, Dahl JB. Adductor canal block for postoperative pain treatment after revision knee arthroplasty: a blinded, randomized, placebo-controlled study. PLoS One. 2014 Nov 11;9(11):e111951. doi: 10.1371/journal.pone.0111951. eCollection 2014.</citation>
    <PMID>25386752</PMID>
  </reference>
  <reference>
    <citation>Jiang X, Wang QQ, Wu CA, Tian W. Analgesic Efficacy of Adductor Canal Block in Total Knee Arthroplasty: A Meta-analysis and Systematic Review. Orthop Surg. 2016 Aug;8(3):294-300. doi: 10.1111/os.12268. Review.</citation>
    <PMID>27627711</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 4, 2021</study_first_submitted>
  <study_first_submitted_qc>July 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ghada Mohammed AboelFadl</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>levobupivacaine</keyword>
  <keyword>Adductor Canal Block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

